Stifel slashes price target on Evofem Biosciences Inc. [EVFM] – find out why.

Related

Share

Evofem Biosciences Inc. [NASDAQ: EVFM] loss -26.61% on the last trading session, reaching $1.71 price per share at the time. The company report on March 25, 2021 that Evofem Biosciences Announces Pricing of $30 Million Public Offering of Common Stock.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Evofem Biosciences, Inc. (NASDAQ: EVFM) announced the pricing of an underwritten public offering of 17,142,857 shares of its common stock at a price to the public of $1.75 per share. The gross proceeds from the offering to Evofem, before deducting the underwriting discounts and commissions and other offering expenses, are expected to be approximately $30.0 million. The offering is expected to close on or about March 29, 2021, subject to satisfaction of customary closing conditions. In addition, Evofem has granted the underwriters a 30-day option to purchase up to an additional 2,571,428 shares of its common stock at the public offering price, less the underwriting discounts and commissions. All of the shares of common stock in the offering are to be sold by Evofem.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Morgan Stanley and Stifel are acting as joint book-running managers for the offering.

Evofem Biosciences Inc. represents 81.32 million in outstanding shares, while the company has a total market value of $144.27 million with the latest information. EVFM stock price has been found in the range of $1.695 to $1.87.

If compared to the average trading volume of 4.19M shares, EVFM reached a trading volume of 26745759 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about Evofem Biosciences Inc. [EVFM]:

Stifel have made an estimate for Evofem Biosciences Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on October 02, 2020. While these analysts kept the previous recommendation, Morgan Stanley raised their target price to Equal-Weight. The new note on the price target was released on August 20, 2020, representing the official price target for Evofem Biosciences Inc. stock. Previously, the target price had yet another raise to $11, while Piper Sandler analysts kept a Overweight rating on EVFM stock.

The Average True Range (ATR) for Evofem Biosciences Inc. is set at 0.36, with the Price to Sales ratio for EVFM stock in the period of the last 12 months amounting to 360.68. The Price to Book ratio for the last quarter was 85.50, with the Price to Cash per share for the same quarter was set at 0.58.

Trading performance analysis for EVFM stock

Evofem Biosciences Inc. [EVFM] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -37.13. With this latest performance, EVFM shares dropped by -59.29% in over the last four-week period, additionally sinking by -19.34% over the last 6 months – not to mention a drop of -61.14% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for EVFM stock in for the last two-week period is set at 26.35, with the RSI for the last a single of trading hit 18.52, and the three-weeks RSI is set at 31.87 for Evofem Biosciences Inc. [EVFM]. The present Moving Average for the last 50 days of trading for this stock 3.1942, while it was recorded at 2.3980 for the last single week of trading, and 2.8058 for the last 200 days.

Evofem Biosciences Inc. [EVFM]: A deeper dive into fundamental analysis

When it comes to the capital structure of this company, Evofem Biosciences Inc. [EVFM] has a Total Debt to Total Equity ratio set at 1.26. Additionally, EVFM Total Debt to Total Capital is recorded at 1.24, with Total Debt to Total Assets ending up at 0.70.

Reflecting on the efficiency of the workforce at the company, Evofem Biosciences Inc. [EVFM] managed to generate an average of -$1,510,057 per employee.Evofem Biosciences Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.20 and a Current Ratio set at 1.30.

Evofem Biosciences Inc. [EVFM]: An earnings per share (EPS) analysis

With the latest financial reports released by the company, Evofem Biosciences Inc. posted -0.4/share EPS, while the average EPS was predicted by analysts to be reported at -0.32/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -25.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for EVFM.

An analysis of insider ownership at Evofem Biosciences Inc. [EVFM]

There are presently around $73 million, or 40.20% of EVFM stock, in the hands of institutional investors. The top three institutional holders of EVFM stocks are: INVESCO LTD. with ownership of 12,699,331, which is approximately 0.224% of the company’s market cap and around 3.00% of the total institutional ownership; LINK FUND SOLUTIONS LTD, holding 9,138,504 shares of the stock with an approximate value of $15.63 million in EVFM stocks shares; and BLACKROCK INC., currently with $8.91 million in EVFM stock with ownership of nearly 5.243% of the company’s market capitalization.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Positions in Evofem Biosciences Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 51 institutional holders increased their position in Evofem Biosciences Inc. [NASDAQ:EVFM] by around 3,028,226 shares. Additionally, 50 investors decreased positions by around 6,179,742 shares, while 23 investors held positions by with 33,255,740 shares. The mentioned changes placed institutional holdings at 42,463,708 shares, according to the latest SEC report filing. EVFM stock had 20 new institutional investments in for a total of 674,464 shares, while 27 institutional investors sold positions of 4,664,130 shares during the same period.

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam